AHRR contributes to inflammatory lymphangiogenesis by activating the EPAS1/VEGFD signaling axis in head and neck cancer.
Am J Cancer Res
; 12(2): 537-548, 2022.
Article
in En
| MEDLINE
| ID: mdl-35261785
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Type of study:
Risk_factors_studies
Language:
En
Journal:
Am J Cancer Res
Year:
2022
Document type:
Article
Affiliation country:
China
Country of publication:
United States